You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

List of Excipients in Branded Drug VIZZ


✉ Email this page to a colleague

« Back to Dashboard


Company Tradename Ingredient NDC Excipient Potential Generic Entry
LENZ Therapeutics Inc VIZZ aceclidine 84226-100 EDETATE DISODIUM 2030-07-31
LENZ Therapeutics Inc VIZZ aceclidine 84226-100 MANNITOL 2030-07-31
LENZ Therapeutics Inc VIZZ aceclidine 84226-100 POLYSORBATE 80 2030-07-31
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Excipient Strategy and Commercial Opportunities for VIZZ

Last updated: February 27, 2026

What is the Excipient Strategy for VIZZ?

VIZZ, a pharmaceutical product, employs a specific excipient framework to optimize stability, bioavailability, and manufacturability. The excipient selection aims to enhance drug performance, comply with regulatory standards, and reduce manufacturing costs.

Core Excipients Used in VIZZ

  • Fillers/Diluents: Microcrystalline cellulose, lactose monohydrate.
  • Binders: Hydroxypropyl methylcellulose (HPMC), povidone.
  • Disintegrants: croscarmellose sodium.
  • Lubricants: magnesium stearate.
  • Coating Agents: hydroxypropyl cellulose, polymer-based coatings.

Rationale Behind Excipient Choices

  • Microcrystalline cellulose provides compressibility and stability.
  • Lactose ensures palatability and acts as a filler.
  • HPMC and povidone improve tablet cohesion and disintegration.
  • Croscarmellose sodium enhances dispersibility.
  • Magnesium stearate reduces friction during tablet formation.
  • Coating agents protect the drug, improve appearance, and mask taste.

Regulatory Considerations

Selection aligns with FDA and EMA guidelines, emphasizing excipients with well-documented safety profiles, acceptable residual levels, and compatibility with active pharmaceutical ingredients (APIs).

Commercial Opportunities in Excipient Market for VIZZ

Market Size and Growth

The global pharmaceutical excipients market was valued at USD 6.4 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2028 [1]. Increased demand for controlled-release formulations, generic drugs, and biologics drives this expansion.

Key Opportunities

  • Specialty Excipients: Push for excipients with enhanced functionalities such as controlled release, taste masking, or improved bioavailability presents potential for premium pricing.
  • Green and Natural Excipients: Rising consumer preference favors excipients derived from natural sources, offering opportunities for brands like VIZZ to position as sustainable.
  • High-Purity Excipients: Critical for biologics and sensitive molecules, high-purity grades command higher margins.
  • Regional Expansion: Emerging markets in Asia-Pacific show heightened demand, driven by increasing pharmaceutical manufacturing capacity.

Competitive Landscape

Major suppliers include BASF, DuPont, Ashland, and negligible generic excipient producers. Tapping into niche markets with customized excipient blends and specialty formulations can differentiate VIZZ in the marketplace.

Regulatory and Supply Chain Strategies

  • Establishing supplier partnerships ensures consistent quality and supply.
  • Navigating evolving regulatory landscapes requires early engagement with authorities and adherence to cGMP standards.
  • Adoption of multifunctional excipients reduces process complexity and costs.

Strategic Recommendations

  • Develop or source excipients with improved stability and compatibility for VIZZ’s API.
  • Invest in natural or biodegradable excipients to align with global sustainability initiatives.
  • Leverage regional manufacturing hubs to serve emerging markets effectively.
  • Focus on formulation innovations that can command premium pricing and market differentiation.

Key Takeaways

  • VIZZ's excipient strategy centers on selecting high-quality, compatible ingredients aligned with regulatory standards.
  • The global excipient market's growth offers multiple avenues, especially with specialty and natural products.
  • Regional expansion and formulation innovation can translate into competitive advantages.
  • Establishing supply chain reliability and regulatory compliance enhances market access.
  • Customizing excipient formulations for VIZZ allows differentiation in crowded markets.

FAQs

Q1: How does excipient choice impact VIZZ’s patentability?
Excipient selection can enhance formulation patent claims, especially if novel or with unexpected synergistic effects.

Q2: What are the key regulatory concerns for excipients in VIZZ?
Ensuring excipients meet safety, purity, and compatibility standards set by FDA, EMA, and other authorities is critical.

Q3: Can natural excipients replace synthetic ones in VIZZ formulations?
Yes, provided they meet performance, stability, and regulatory requirements.

Q4: What is the role of multifunctional excipients in VIZZ's manufacturing?
They reduce formulation complexity and costs by combining functions like disintegration and binder activity.

Q5: How does the excipient market influence VIZZ’s commercialization strategy?
A robust excipient supply and favorable market conditions enable scalable manufacturing and competitive positioning.


References

[1] MarketsandMarkets. (2022). Pharmaceutical Excipients Market Size, Trends & Forecasts. Retrieved from https://www.marketsandmarkets.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.